Skip to main content

Educate. Empower. Improve Care.

Medlive’s digital medical education platform delivers timely patient-centered scientific content driven by medical experts — and shared through a powerful network of clinicians, patients, caregivers, and partners.

100M+ patients impacted

Medlive is a trusted leader in expert-led digital medical education and learner engagement.

In partnership with leading medical centers, advocacy groups, associations and medical societies, we empower clinicians, patients, and caregivers with the latest medical insights on managing cancers, neurological disorders, rare diseases, and more.

350+

Activities per Year

150+

Partners

Our Stakeholders

Learners

Clinicians, patients, and caregivers access educational sessions on recent medical advances.

Become a Learner

Partners

Partners collaborate on expert-led education and amplify their mission through the Medlive network.

Partner with us

Supporters

Life science companies support best-in-class patient-centered education.

Learn more

Ready to learn from top medical experts?

Medlive’s video education is available to clinicians interested in staying abreast of the latest advances in medicine and patients and caregivers interested in hearing from others living with their condition.

The Medlive Difference

Patient-Centered Approach

Our Partners

Medlive partners with mission-driven organizations to provide members with relevant, timely, and trusted education.

Latest from our Experts

Meet Medlive at the 2025 ASCO Annual MeetingNews

Meet Medlive at the 2025 ASCO Annual Meeting

Medlive is excited to exhibit at the 2025 ASCO Annual Meeting, taking place May 30…
April 21, 20252 min Read More
Meet Medlive at the 2025 AAN Annual MeetingNews

Meet Medlive at the 2025 AAN Annual Meeting

Medlive is excited to exhibit at the 2025 AAN Annual Meeting, taking place April 5…
February 24, 20252 min Read More

Subscribe

Subscribe to our newsletter for the latest updates and insights.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.